RSA
IHE icon

Robertson Stephens Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Robertson Stephens Advisors’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,101
Closed -$212K – 68
2017
Q2 		$212K Hold
4,101
– – 0.19% 64
2017
Q1 		$206K Buy
+4,101
New +$203K 0.18% 80

Other funds holding IHE

CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AWA
ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
RTS
Round Table Services Westfield, New Jersey $508M AUM 16.36% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Robertson Stephens Advisors's IHE Position: Q3 2017 in Review

Robertson Stephens Advisors sold out of iShares US Pharmaceuticals ETF (IHE) in Q3 2017, closing a stake of 4,101 shares — an estimated $212K sold.

Robertson Stephens Advisors first reported a position in IHE in Q1 2017 and held it in 2 quarters. The position peaked at $212K in Q2 2017. 101 funds tracked by Wall St. Rank hold IHE as of Q3 2017.

  • Robertson Stephens Advisors reported no remaining iShares US Pharmaceuticals ETF position as of Q3 2017 after selling out during the quarter.
  • Robertson Stephens Advisors sold 4,101 iShares US Pharmaceuticals ETF shares in Q3 2017, an estimated $212K.
  • Robertson Stephens Advisors first reported a position in iShares US Pharmaceuticals ETF in Q1 2017 and held it in 2 quarters.
  • Robertson Stephens Advisors's iShares US Pharmaceuticals ETF position peaked at $212K in Q2 2017.
  • 101 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2017.

Based on Robertson Stephens Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.